Back

Betaine therapy of cardiac hypertrophy through inhibition of Hydroxy-carboxylic Acid Receptor 1 signaling

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Myocardial remodelling (1) Cardiac Hypertrophy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Miss Lihong Yao

Affiliated Hospital of Nantong University, Nantong (China)

7 More presentations in this session

Presentation thumbnail
  A high-throughput screening strategy identifies adenosine 5'-monophosphate as a novel enhancing molecule of the cardio-protective enzyme 5-oxoprolinase (OPLAH).
Mr J. Esquivel Gaytan (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Melanocortin 1 receptor deficiency protects against pathological cardiac hypertrophy
Ms A. Suominen (Turku, FI)
Abstract Slides Video
Presentation thumbnail
ERBB4 stimulation mitigates atrial fibrillation and remodeling in a porcine DOCA model
Doctor M. Tubeeckx (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
The anti-fibrotic effect of atrial natriuretic peptide depends on myocardial accumulation of the peptide in rat heart
Professor S. Hatem (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Rimeporide, a first in class Na/H exchanger-1 inhibitor, ameliorates right ventricular dysfunction and pulmonary arterial hypertension in a SuHx model
Doctor G. Milano (Lausanne, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial remodelling (1)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Webinar
Elevating cardiac expertise: practical approach to left ventricular hypertrophy phenotypes assessment
thumbnail
Congress Presentation
Multimodality imaging in hypertrophied hearts
thumbnail
Congress Presentation
Contemporary treatment of hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources